These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12646674)

  • 1. CD40 ligand--assessing risk instead of damage?
    Freedman JE
    N Engl J Med; 2003 Mar; 348(12):1163-5. PubMed ID: 12646674
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CD40 ligand in acute coronary syndromes.
    Kritharides L; Lau GT; Freedman B
    N Engl J Med; 2003 Jun; 348(25):2575-7; author reply 2575-7. PubMed ID: 12815146
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble CD40 ligand in acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; van den Brand MJ; Boersma E; Zeiher AM; Simoons ML;
    N Engl J Med; 2003 Mar; 348(12):1104-11. PubMed ID: 12646667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soluble CD40 ligand: a potential marker of cardiovascular risk].
    San Miguel Hernández A; Inglada-Galiana L; García Iglesias R; Alonso Castillejos N; Martín Gil FJ
    Rev Clin Esp; 2007 Sep; 207(8):418-21. PubMed ID: 17688874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
    Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
    J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand in acute coronary syndromes.
    Conde ID; Kleiman NS
    N Engl J Med; 2003 Jun; 348(25):2575-7; author reply 2575-7. PubMed ID: 12816111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of unstable angina pectoris. Thrombocyte aggregation inhibition improves chances for survival].
    Z Kardiol; 1998 Aug; 87(8 Suppl Thrombozy):1-3. PubMed ID: 9789356
    [No Abstract]   [Full Text] [Related]  

  • 9. Regimen lowers rate of coronary events in diabetes.
    Husten L
    Lancet; 1998 Aug; 352(9129):711. PubMed ID: 9728999
    [No Abstract]   [Full Text] [Related]  

  • 10. On the use of abciximab in percutaneous coronary intervention.
    Iversen AZ
    Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction.
    Szabo S; Etzel D; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    J Thromb Thrombolysis; 2005 Dec; 20(3):155-61. PubMed ID: 16261288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
    Hézard N; Metz D; Garnotel R; Droullé C; Potron G; Nguyen P
    J Mal Vasc; 2000 Dec; 25(5):343-348. PubMed ID: 11148396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Young JJ
    J Invasive Cardiol; 2005 Jun; 17(6):300-1. PubMed ID: 16003003
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of angioplasty with stenting in acute myocardial infarction.
    Herrmann HC
    N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
    Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
    Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.
    Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L
    Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction.
    Piorkowski M; Priess J; Weikert U; Jaster M; Schwimmbeck PL; Schultheiss HP; Rauch U
    Thromb Haemost; 2005 Aug; 94(2):422-6. PubMed ID: 16113834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation is associated with myocardial infarction in patients with pneumonia.
    Cangemi R; Casciaro M; Rossi E; Calvieri C; Bucci T; Calabrese CM; Taliani G; Falcone M; Palange P; Bertazzoni G; Farcomeni A; Grieco S; Pignatelli P; Violi F; ;
    J Am Coll Cardiol; 2014 Nov; 64(18):1917-25. PubMed ID: 25444147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: ready for prime time.
    Anderson HV
    J Invasive Cardiol; 2000 Mar; 12(3):140-1. PubMed ID: 10877555
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lysis of an intracoronary thrombus with a glycoprotein IIb/IIIa antagonist].
    Ammann P; Naegeli B; Schuiki E; Bertel O
    Schweiz Med Wochenschr; 2000 Mar; 130(9):336. PubMed ID: 10746274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.